Add like
Add dislike
Add to saved papers

Small-scale production of 67 Cu for a preclinical study via the 64 Ni(α, p) 67 Cu channel.

INTRODUCTION: Copper-67 is an attractive beta emitter for targeted radionuclide therapy. However, the availability of 67 Cu limits its potential use in a wide range of applications. In this study, we propose an easy small-scale production of 67 Cu using 64 Ni target for a preclinical study.

METHODS: 67 Cu was produced from an electrodeposited 64 Ni target via the 64 Ni(α, p)67 Cu-reaction with a 36 MeV alpha beam at 15 eμA (electrical microampere) conducted for 7 h. The chemical separation process of 67 Cu from the 64 Ni target was performed following by our routine procedure of 64 Cu production using cation exchange resin, AG50W-X8, with minor modification. The target and its holder were redesigned in the preparation.

RESULTS: The 67 Cu product was obtained with a yield of 55 ± 10 MBq at the end of bombardment (EOB), and the yield was 527 ± 96 kBq/μAh at the EOB. The copper impurity in the product was low (0.71 ± 0.21 μg) and the product was suitable for a preclinical study.

CONCLUSIONS: We produced 67 Cu with sufficient activity and quality for a preclinical study using a 64 Ni-target. This production method also showed advantages as a routine method, i.e., shorten the processing time, reducing the radiation exposure and ready target recycling, when compared with that of a conventional Zn-target used for 67 Cu production.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app